DRUG · Mapped RxNorm record
Dolutegravir 50 mg
Normalized identity: dolutegravir 50 MGView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects
NCT03224338
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedDolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIV II Infectionunresolved
Interventions
Dolutegravir 50 mgDRUG · verified · RxNorm: dolutegravir 50 MG
Sponsors & collaborators
Blueclinical, Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03224338 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.